Gc Biopharma Corp

This early-stage study tested the safety of a new experimental drug called MG1113 for people with severe hemophilia. Fifteen adult male patients received weekly injections for eight weeks while researchers carefully monitored for side effects. The main goal was to understand how …

This study followed patients with Hunter syndrome for about one year to check the long-term safety and effectiveness of Hunterase enzyme replacement therapy. It included 30 patients who had already been receiving this treatment for at least six months. Researchers monitored walki…